Chemist + Druggist is part of Pharma Intelligence UK Limited

This is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By


Lloydspharmacy names Kevin Birch as new CEO

Lloydspharmacy has named Kevin Birch – the chief retail officer at its parent company McKesson UK – as its new CEO, following three years in his current post.

Mr Birch has over 30 years of experience in retail, having previously held senior positions at Walgreens Boots Alliance – the parent company of Lloydspharmacy rival Boots.

Following his time at Walgreens Boots Alliance, Mr Birch was CEO at the Avicenna pharmacy group.

Read more: Lloydspharmacy boss steps down after three years in role

As Lloydspharmacy CEO, he will head up the multiple's retail business, including MASTA Travel and the healthcare services division.

It follows the departure of former McKesson CEO Toby Anderson in May after almost four years in the post.

Private equity firm Aurelius Group completed the acquisition of McKesson UK in early April 7.

Mr Birch said he was "delighted" to be taking on his new role. "I look forward to working with our colleagues on creating a new future for Lloydspharmacy," he commented. 


Pharmacy Manager
Newquay, Cornwall
£ Competitive

Apply Now
Latest News & Analysis
See All



Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts